RESUMO
Breast cancer is the most common cancer diagnosed in women, accounting for an estimated 30% of all new cancer diagnoses in women in 2022. Advances in breast cancer treatment have reduced the mortality rate over the past 25 years by up to 34% but not all groups have benefitted equally from these improvements. These disparities span the continuum of care from screening to the receipt of guideline-concordant therapy and survivorship. At the 2022 American College of Surgeons Clinical Congress, a panel session was dedicated to educating and discussing methods of addressing these disparities in a coordinated manner. While there are multilevel solutions to address these disparities, this article focuses on screening, genetic testing, reconstruction, and oncofertility.
Assuntos
Neoplasias da Mama , Preservação da Fertilidade , Feminino , Humanos , Neoplasias da Mama/diagnóstico , Neoplasias da Mama/genética , Neoplasias da Mama/terapia , Detecção Precoce de Câncer , Testes Genéticos , Disparidades em Assistência à SaúdeRESUMO
Vascular access for hemodialysis by arteriovenous fistula (AVF) is broadly recommended. Vein depth in many obese patients makes cannulation of an otherwise successful AVF difficult or impossible. We reviewed the case of an obese patient where liposuction was used to remove adipose tissue resulting in a superficial and easily accessed AVF. An endoscopic vein harvesting device was used to shield the vein during liposuction.
